基于影像的实体瘤定量生物标志物
近几十年来,基于影像的肿瘤定量与表征生物标志物技术快速发展,从手工一维和二维尺寸测量演进到利用影像采集、处理与分析算法的进步。然而,绝大多数新技术仍面临临床验证的重大挑战,最新技术进展与日常临床实践中使用的影像生物标志物之间仍存在巨大差距。本文综述了影像生物标志物的当前技术水平及其在实体瘤表征和预测性定量中的应用,并回顾了基于人工智能的肿瘤表征方法,如放射组学方法和深度学习。
要点
- 影像生物标志物从手工尺寸测量发展到利用影像处理与分析算法。
- 大多数新型影像生物标志物技术仍缺乏临床验证,与日常实践存在差距。
- 人工智能算法用于大规模数据集的应用推动了影像生物标志物领域的发展。
核心结论
- 影像生物标志物领域技术发展迅速,但临床验证仍是绝大多数新技术的重大挑战,最新技术进展与日常临床实践所用影像生物标志物之间仍存在重大差距。
研究设计与样本
- 综述文章,回顾了影像生物标志物的当前技术水平及其在实体瘤表征和预测性定量中的应用,以及人工智能算法在图像处理和分析中的最新进展。
局限性
- 临床验证仍是绝大多数新型影像生物标志物技术的重大挑战。
- 最新技术进展与日常临床实践中使用的影像生物标志物之间仍存在重大差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The last few decades have witnessed tremendous technological developments in image-based biomarkers for tumor quantification and characterization. Initially limited to manual one- and two-dimensional size measurements, image biomarkers have evolved to harness developments not only in image acquisition technology but also in image processing and analysis algorithms. At the same time, clinical validation remains a major challenge for the vast majority of these novel techniques, and there is still a major gap between the latest technological developments and image biomarkers used in everyday clinical practice. Currently, the imaging biomarker field is attracting increasing attention not only because of the tremendous interest in cutting-edge therapeutic developments and personalized medicine but also because of the recent progress in the application of artificial intelligence (AI) algorithms to large-scale datasets. Thus, the goal of the present article is to review the current state of the art for image biomarkers and their use for characterization and predictive quantification of solid tumors. Beginning with an overview of validated imaging biomarkers in current clinical practice, we proceed to a review of AI-based methods for tumor characterization, such as radiomics-based approaches and deep learning.Key Points• Recent years have seen tremendous technological developments in image-based biomarkers for tumor quantification and characterization.• Image-based biomarkers can be used on an ongoing basis, in a non-invasive (or mildly invasive) way, to monitor the development and progression of the disease or its response to therapy.• We review the current state of the art for image biomarkers, as well as the recent developments in artificial intelligence (AI) algorithms for image processing and analysis.
引用
- Savadjiev P, Chong J, Dohan A, et al. Image-based biomarkers for solid tumor quantification. Eur Radiol. 2019. PMID: 30963275. doi:10.1007/s00330-019-06169-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。